Genetic approaches to understanding human obesity.

Obesity and its associated comorbidities represent one of the biggest public health challenges facing the world today. The heritability of body weight is high, and genetic variation plays a major role in determining the interindividual differences in susceptibility or resistance to the obesogenic environment. Here we discuss how genetic studies in humans have contributed to our understanding of the central pathways that govern energy homeostasis. We discuss how the arrival of technological advances such as next-generation sequencing will result in a major acceleration in the pace of gene discovery. The study of patients harboring these genetic variants has informed our understanding of the molecular and physiological pathways involved in energy homeostasis. We anticipate that future studies will provide the framework for the development of a more rational targeted approach to the prevention and treatment of genetically susceptible individuals.

[1]  I. Pogozheva,et al.  Pharmacological Chaperones Restore Function to MC4R Mutants Responsible for Severe Early-Onset Obesity , 2010, Journal of Pharmacology and Experimental Therapeutics.

[2]  P. Shannon,et al.  Exome sequencing identifies the cause of a Mendelian disorder , 2009, Nature Genetics.

[3]  R. Krauss,et al.  Phenotypic effects of leptin replacement on morbid obesity, diabetes mellitus, hypogonadism, and behavior in leptin-deficient adults. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[4]  Tim Cheetham,et al.  Clinical spectrum of obesity and mutations in the melanocortin 4 receptor gene. , 2003, The New England journal of medicine.

[5]  Sarah M. Williams,et al.  Maternal high-fat diet triggers lipotoxicity in the fetal livers of nonhuman primates. , 2009, The Journal of clinical investigation.

[6]  Spain,et al.  Clinical and molecular genetic spectrum of congenital deficiency of the leptin receptor. , 2007, The New England journal of medicine.

[7]  S. O’Rahilly,et al.  Heterozygosity for a POMC-Null Mutation and Increased Obesity Risk in Humans , 2006, Diabetes.

[8]  T. Groen,et al.  in Adult Mice Leads to Ob Supplemental Data S 1 Disruption of Intraflagellar Transport esity and Slow-Onset Cystic Kidney Disease , 2022 .

[9]  A. von Deimling,et al.  A role for beta-melanocyte-stimulating hormone in human body-weight regulation. , 2006, Cell metabolism.

[10]  Emily H Turner,et al.  Targeted Capture and Massively Parallel Sequencing of Twelve Human Exomes , 2009, Nature.

[11]  J. Stockman An Obesity-Associated FTO Gene Variant and Increased Energy Intake in Children , 2010 .

[12]  R. Cone,et al.  Targeted Disruption of the Melanocortin-4 Receptor Results in Obesity in Mice , 1997, Cell.

[13]  A. Zinn,et al.  Postnatal Sim1 Deficiency Causes Hyperphagic Obesity and Reduced Mc4r and Oxytocin Expression , 2010, The Journal of Neuroscience.

[14]  I. Farooqi The severely obese patient—a genetic work-up , 2006, Nature Clinical Practice Endocrinology &Metabolism.

[15]  S. O’Rahilly,et al.  Serum ghrelin levels are inversely correlated with body mass index, age, and insulin concentrations in normal children and are markedly increased in Prader-Willi syndrome. , 2003, The Journal of clinical endocrinology and metabolism.

[16]  Tanya M. Teslovich,et al.  Basal body dysfunction is a likely cause of pleiotropic Bardet–Biedl syndrome , 2003, Nature.

[17]  R. Cone Anatomy and regulation of the central melanocortin system , 2005, Nature Neuroscience.

[18]  S. O’Rahilly,et al.  Prevalence of Melanocortin-4 Receptor Deficiency in Europeans and Their Age-Dependent Penetrance in Multigenerational Pedigrees , 2008, Diabetes.

[19]  Xiao-Bing Gao,et al.  Leptin Receptor Signaling in Midbrain Dopamine Neurons Regulates Feeding , 2006, Neuron.

[20]  M. Tschöp,et al.  A role for β-melanocyte-stimulating hormone in human body-weight regulation , 2006 .

[21]  S. O’Rahilly,et al.  A de novo mutation affecting human TrkB associated with severe obesity and developmental delay , 2004, Nature Neuroscience.

[22]  M. McCarthy,et al.  Regulation of Fto/Ftm gene expression in mice and humans. , 2008, American journal of physiology. Regulatory, integrative and comparative physiology.

[23]  S. Heymsfield,et al.  Low dose leptin administration reverses effects of sustained weight-reduction on energy expenditure and circulating concentrations of thyroid hormones. , 2002, The Journal of clinical endocrinology and metabolism.

[24]  Tanya M. Teslovich,et al.  Association analyses of 249,796 individuals reveal 18 new loci associated with body mass index , 2010 .

[25]  A. Zinn,et al.  Oxytocin deficiency mediates hyperphagic obesity of Sim1 haploinsufficient mice. , 2008, Molecular endocrinology.

[26]  J. Wardle,et al.  Obesity associated genetic variation in FTO is associated with diminished satiety. , 2008, The Journal of clinical endocrinology and metabolism.

[27]  S. Seminara,et al.  Reproductive functions of kisspeptin and Gpr54 across the life cycle of mice and men , 2009, Peptides.

[28]  G. Hervey The effects of lesions in the hypothalamus in parabiotic rats , 1959, The Journal of physiology.

[29]  J Licinio,et al.  Human leptin deficiency caused by a missense mutation: multiple endocrine defects, decreased sympathetic tone, and immune system dysfunction indicate new targets for leptin action, greater central than peripheral resistance to the effects of leptin, and spontaneous correction of leptin-mediated defe , 1999, The Journal of clinical endocrinology and metabolism.

[30]  G. Mcclearn,et al.  The body-mass index of twins who have been reared apart. , 1990, The New England journal of medicine.

[31]  Robert Plomin,et al.  Evidence for a strong genetic influence on childhood adiposity despite the force of the obesogenic environment. , 2008, The American journal of clinical nutrition.

[32]  M. Jarvelin,et al.  A Common Variant in the FTO Gene Is Associated with Body Mass Index and Predisposes to Childhood and Adult Obesity , 2007, Science.

[33]  S. O’Rahilly,et al.  Congenital leptin deficiency due to homozygosity for the Delta133G mutation: report of another case and evaluation of response to four years of leptin therapy. , 2004, The Journal of clinical endocrinology and metabolism.

[34]  A Tremblay,et al.  The response to long-term overfeeding in identical twins. , 1990, The New England journal of medicine.

[35]  J. Greenfield,et al.  Melanocortin Signalling and the Regulation of Blood Pressure in Human Obesity , 2011, Journal of neuroendocrinology.

[36]  Martin J. Aryee,et al.  Personalized Epigenomic Signatures That Are Stable Over Time and Covary with Body Mass Index , 2010, Science Translational Medicine.

[37]  Min Chen,et al.  Gsα Mutations and Imprinting Defects in Human Disease , 2002 .

[38]  Joy Hirsch,et al.  Leptin reverses weight loss-induced changes in regional neural activity responses to visual food stimuli. , 2008, The Journal of clinical investigation.

[39]  N. Martin,et al.  Abnormalities of the somatotrophic axis in the obese agouti mouse , 2006, International Journal of Obesity.

[40]  Min Chen,et al.  Gs(alpha) mutations and imprinting defects in human disease. , 2002, Annals of the New York Academy of Sciences.

[41]  S. Woods,et al.  Central nervous system control of food intake , 2000, Nature.

[42]  S. Fulton,et al.  Leptin Regulation of the Mesoaccumbens Dopamine Pathway , 2006, Neuron.

[43]  A. Stunkard,et al.  A twin study of human obesity. , 1986, JAMA.

[44]  J. Hodges,et al.  Hyperphagia, Severe Obesity, Impaired Cognitive Function, and Hyperactivity Associated With Functional Loss of One Copy of the Brain-Derived Neurotrophic Factor (BDNF) Gene , 2006, Diabetes.

[45]  A. Grüters,et al.  Obesity due to proopiomelanocortin deficiency: three new cases and treatment trials with thyroid hormone and ACTH4-10. , 2003, The Journal of clinical endocrinology and metabolism.

[46]  Jens C. Brüning,et al.  Inactivation of the Fto gene protects from obesity , 2009, Nature.

[47]  Ellen Kampman,et al.  Genome-wide association yields new sequence variants at seven loci that associate with measures of obesity , 2009, Nature Genetics.

[48]  S. O’Rahilly,et al.  Obesity due to melanocortin 4 receptor (MC4R) deficiency is associated with increased linear growth and final height, fasting hyperinsulinemia, and incompletely suppressed growth hormone secretion. , 2011, The Journal of clinical endocrinology and metabolism.

[49]  J. Michaud,et al.  Sim1 haploinsufficiency causes hyperphagia, obesity and reduction of the paraventricular nucleus of the hypothalamus. , 2001, Human molecular genetics.

[50]  C. Mantzoros,et al.  Leptin in Immunology1 , 2005, The Journal of Immunology.

[51]  C. Albanese,et al.  Crucial role of the central leptin receptor in murine Trypanosoma cruzi (Brazil strain) infection. , 2010, The Journal of infectious diseases.

[52]  S. O’Rahilly,et al.  Dominant and recessive inheritance of morbid obesity associated with melanocortin 4 receptor deficiency. , 2000, The Journal of clinical investigation.

[53]  W. Elliott Modulation of Blood Pressure by Central Melanocortinergic Pathways , 2010 .

[54]  Chris P. Ponting,et al.  The Obesity-Associated FTO Gene Encodes a 2-Oxoglutarate-Dependent Nucleic Acid Demethylase , 2007, Science.

[55]  G. Uhl,et al.  Brain-derived neurotrophic factor and obesity in the WAGR syndrome. , 2008, The New England journal of medicine.

[56]  A. Prentice,et al.  Effects of recombinant leptin therapy in a child with congenital leptin deficiency. , 1999, The New England journal of medicine.

[57]  J. Kaprio,et al.  The heritability of body mass index among an international sample of monozygotic twins reared apart. , 1996, International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity.

[58]  M. Hurles,et al.  Large, rare chromosomal deletions associated with severe early-onset obesity , 2010, Nature.

[59]  D. Swaab,et al.  Alterations in the hypothalamic paraventricular nucleus and its oxytocin neurons (putative satiety cells) in Prader-Willi syndrome: a study of five cases. , 1995, The Journal of clinical endocrinology and metabolism.

[60]  S. O’Rahilly,et al.  Studies of the SIM1 gene in relation to human obesity and obesity-related traits , 2007, International Journal of Obesity.

[61]  S. O’Rahilly,et al.  Obesity and impaired prohormone processing associated with mutations in the human prohormone convertase 1 gene , 1997, Nature Genetics.

[62]  Christian Gieger,et al.  Six new loci associated with body mass index highlight a neuronal influence on body weight regulation , 2009, Nature Genetics.

[63]  Roger D. Cox,et al.  Overexpression of Fto leads to increased food intake and results in obesity , 2010, Nature Genetics.

[64]  S. O’Rahilly,et al.  A POMC variant implicates beta-melanocyte-stimulating hormone in the control of human energy balance. , 2006, Cell metabolism.

[65]  Marwan Shinawi,et al.  Prader-Willi phenotype caused by paternal deficiency for the HBII-85 C/D box small nucleolar RNA cluster , 2008, Nature Genetics.

[66]  O. Gavrilova,et al.  Central nervous system imprinting of the G protein G(s)alpha and its role in metabolic regulation. , 2009, Cell metabolism.

[67]  J. Holst,et al.  Small-intestinal dysfunction accompanies the complex endocrinopathy of human proprotein convertase 1 deficiency. , 2003, The Journal of clinical investigation.

[68]  Subhajyoti De,et al.  Common variants near MC4R are associated with fat mass, weight and risk of obesity , 2008, Nature Genetics.

[69]  S. O’Rahilly,et al.  Mutations in the amino-terminal region of proopiomelanocortin (POMC) in patients with early-onset obesity impair POMC sorting to the regulated secretory pathway. , 2008, The Journal of clinical endocrinology and metabolism.

[70]  S. O’Rahilly,et al.  Congenital leptin deficiency is associated with severe early-onset obesity in humans , 1997, Nature.

[71]  A. Zinn,et al.  Sim1 haploinsufficiency impairs melanocortin-mediated anorexia and activation of paraventricular nucleus neurons. , 2006, Molecular endocrinology.

[72]  K. Clément,et al.  Melanocortin-4 receptor mutations are a frequent and heterogeneous cause of morbid obesity. , 2000, The Journal of clinical investigation.

[73]  J. Friedman,et al.  Obesity in the new millennium , 2000, Nature.

[74]  C. Saper,et al.  Distributions of leptin receptor mRNA isoforms in the rat brain , 1998, The Journal of comparative neurology.

[75]  R. A. Price,et al.  Genetics of obesity in adult adoptees and their biological siblings. , 1989, BMJ.

[76]  A. Grüters,et al.  Severe early-onset obesity, adrenal insufficiency and red hair pigmentation caused by POMC mutations in humans , 1998, Nature Genetics.

[77]  S. O’Rahilly,et al.  The central melanocortin system directly controls peripheral lipid metabolism. , 2007, The Journal of clinical investigation.

[78]  K. Clément,et al.  Melanocortin 4 receptor mutations in a large cohort of severely obese adults: prevalence, functional classification, genotype-phenotype relationship, and lack of association with binge eating. , 2006, The Journal of clinical endocrinology and metabolism.

[79]  P. Shannon,et al.  Analysis of Genetic Inheritance in a Family Quartet by Whole-Genome Sequencing , 2010, Science.

[80]  A. Strosberg,et al.  A leptin missense mutation associated with hypogonadism and morbid obesity , 1998, Nature Genetics.

[81]  Graham M Lord,et al.  Beneficial effects of leptin on obesity, T cell hyporesponsiveness, and neuroendocrine/metabolic dysfunction of human congenital leptin deficiency. , 2002, The Journal of clinical investigation.

[82]  C. Mantzoros,et al.  Role of leptin in the neuroendocrine response to fasting , 1996, Nature.

[83]  D. Stec,et al.  Melanocortin-4 Receptor–Deficient Mice Are Not Hypertensive or Salt-Sensitive Despite Obesity, Hyperinsulinemia, and Hyperleptinemia , 2005, Hypertension.

[84]  J. Brobeck,et al.  Hypothalamic Control of Food Intake in Rats and Cats * , 1951, The Yale journal of biology and medicine.

[85]  E. H. Goulding,et al.  Brain-derived neurotrophic factor regulates energy balance downstream of melanocortin-4 receptor , 2003, Nature Neuroscience.

[86]  D. Allison,et al.  The genetic epidemiology of thinness , 2001, Obesity reviews : an official journal of the International Association for the Study of Obesity.

[87]  Lee-Jen Wei,et al.  Pooled Association Tests for Rare Variants in Exon-Resequencing Studies , 2010 .

[88]  J. Hoyer,et al.  Modulation of blood pressure by central melanocortinergic pathways. , 2009, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[89]  G. C. Kennedy,et al.  The role of depot fat in the hypothalamic control of food intake in the rat , 1953, Proceedings of the Royal Society of London. Series B - Biological Sciences.

[90]  K. Clément,et al.  A mutation in the human leptin receptor gene causes obesity and pituitary dysfunction , 1998, Nature.

[91]  R. Considine,et al.  Serum immunoreactive-leptin concentrations in normal-weight and obese humans. , 1996, The New England journal of medicine.

[92]  E. Ravussin,et al.  Leptin levels in human and rodent: Measurement of plasma leptin and ob RNA in obese and weight-reduced subjects , 1995, Nature Medicine.

[93]  E. Bullmore,et al.  Leptin Regulates Striatal Regions and Human Eating Behavior , 2007, Science.

[94]  Claire Ainsworth,et al.  Cilia: Tails of the unexpected , 2007, Nature.

[95]  A. Zinn,et al.  Profound obesity associated with a balanced translocation that disrupts the SIM1 gene. , 2000, Human molecular genetics.

[96]  S. O’Rahilly,et al.  Hyperphagia and early-onset obesity due to a novel homozygous missense mutation in prohormone convertase 1/3. , 2007, The Journal of clinical endocrinology and metabolism.

[97]  Minghua Li,et al.  Identification of SH2-B as a key regulator of leptin sensitivity, energy balance, and body weight in mice. , 2005, Cell metabolism.

[98]  M. Maffei,et al.  Positional cloning of the mouse obese gene and its human homologue , 1995, Nature.

[99]  L. Tartaglia,et al.  Evidence That the Diabetes Gene Encodes the Leptin Receptor: Identification of a Mutation in the Leptin Receptor Gene in db/db Mice , 1996, Cell.

[100]  J. Friedman,et al.  Leptin's effect on puberty in mice is relayed by the ventral premammillary nucleus and does not require signaling in Kiss1 neurons. , 2011, The Journal of clinical investigation.

[101]  S. Heymsfield,et al.  Low-dose leptin reverses skeletal muscle, autonomic, and neuroendocrine adaptations to maintenance of reduced weight. , 2005, The Journal of clinical investigation.

[102]  S. O’Rahilly,et al.  CNS Leptin Action Modulates Immune Response and Survival in Sepsis , 2010, The Journal of Neuroscience.

[103]  Gregory S. Barsh,et al.  Genetics of body-weight regulation , 2000, Nature.

[104]  P. Beales,et al.  Bardet–Biedl syndrome: beyond the cilium , 2007, Pediatric Nephrology.

[105]  Young-Bum Kim,et al.  Leptin stimulates fatty-acid oxidation by activating AMP-activated protein kinase , 2002, Nature.

[106]  D. Lawlor,et al.  Prevalence and functionality of paucimorphic and private MC4R mutations in a large, unselected European British population, scanned by meltMADGE , 2007, Human mutation.

[107]  M. Schwartz,et al.  Elevated plasma ghrelin levels in Prader–Willi syndrome , 2002, Nature Medicine.

[108]  V. Sheffield,et al.  Requirement of Bardet-Biedl syndrome proteins for leptin receptor signaling , 2009, Human molecular genetics.

[109]  F. Greenway,et al.  Leptin replacement prevents weight loss-induced metabolic adaptation in congenital leptin-deficient patients. , 2010, The Journal of clinical endocrinology and metabolism.

[110]  Beverley Balkau,et al.  Variation in FTO contributes to childhood obesity and severe adult obesity , 2007, Nature Genetics.

[111]  C. Bouchard,et al.  Overfeeding in identical twins: 5-year postoverfeeding results. , 1996, Metabolism: clinical and experimental.

[112]  Robert Plomin,et al.  Childhood Obesity: Genetic and Environmental Overlap With Normal‐range BMI , 2008, Obesity.

[113]  M. Maffei,et al.  Positional cloning of the mouse obese gene and its human homologue , 1994, Nature.

[114]  K. Hummel,et al.  Effects of parabiosis of normal with genetically diabetic mice. , 1969, The American journal of physiology.

[115]  S. O’Rahilly,et al.  A deletion of the HBII-85 class of small nucleolar RNAs (snoRNAs) is associated with hyperphagia, obesity and hypogonadism. , 2009, Human molecular genetics.